MSD, Bayer’s heart failure med Verquvo gains EU approval
22nd July 2021 Uncategorised 0Verquvo cleared for the treatment of symptomatic chronic heart failure in patients with reduced ejection fraction
More: MSD, Bayer’s heart failure med Verquvo gains EU approval
Source: News